CD34 and acute myeloid leukemia: Furthermore, ex vivo culture highlighted that CD34+ blasts from pDC-AML were able to differentiate in pDC, with a greater rate of pDC obtained with pDC-AML blasts than CD34+ cord blood progenitors and blasts from RUNX1mut AML without pDC excess.